Cyto365: €3.9m

Case

12/20/22

Cyto356 – a medical-device start-up developing RondelO™ - a globally unique medical stopcock that prevents mixing of drugs. RondelO™ combats drug incompatibility by design, and it is the only physical device that adds an extra layer of safety for the nurse to do right.

Micael Törnblom, CEO Cyto365, comments: “The EIC Accelerator funding is coming at a time when it is most needed for our company. GAEU has been very supportive during the process and with their previous expertise and knowledge that gave us valuable feedback. The RondelO multi inlet stopcock manifold can now be developed to be able to reach the mass market, to improve the Infusion treatment to address the underserved but well recognized problem of drug incompatibility inline due to human error during administration.”